WallStSmart

LivaNova PLC (LIVN)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 2456% more annual revenue ($35.48B vs $1.39B). MDT leads profitability with a 13.0% profit margin vs -17.5%. LIVN appears more attractively valued with a PEG of 0.73. MDT earns a higher WallStSmart Score of 56/100 (C).

LIVN

Hold

48

out of 100

Grade: D+

Growth: 5.3Profit: 4.0Value: 6.7Quality: 5.0
Piotroski: 3/9Altman Z: 0.84

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LIVN.

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$86.58

$62.24 premium

UndervaluedFair: $24.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIVN2 strengths · Avg: 8.0/10
PEG RatioValuation
0.738/10

Growing faster than its price suggests

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

LIVN4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-19.2%2/10

ROE of -19.2% — below average capital efficiency

EPS GrowthGrowth
-45.6%2/10

Earnings declined 45.6%

Altman Z-ScoreHealth
0.842/10

Distress zone — elevated risk

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : LIVN

The strongest argument for LIVN centers on PEG Ratio, Price/Book. Revenue growth of 12.1% demonstrates continued momentum. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bear Case : LIVN

The primary concerns for LIVN are Piotroski F-Score, Return on Equity, EPS Growth.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Key Dynamics to Monitor

LIVN profiles as a turnaround stock while MDT is a value play — different risk/reward profiles.

LIVN carries more volatility with a beta of 0.95 — expect wider price swings.

LIVN is growing revenue faster at 12.1% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

LivaNova PLC

HEALTHCARE · MEDICAL DEVICES · USA

LivaNova PLC, a medical device company, designs, develops, manufactures and sells therapeutic solutions globally. The company is headquartered in London, the United Kingdom.

Visit Website →

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?